TABLE 1.
Characteristic* | N=141 |
---|---|
Age <30 years, n (%) | 84 (60) |
Race, n (%) | |
White, non-Hispanic | 29 (21) |
Black, non-Hispanic | 87 (62) |
Other/Hispanic | 25 (18) |
Antenatal HIV diagnosis, n (%) | 40 (28) |
HIV RNA <400 copies/mL, n (%) | 90 (74) |
CD4 count, median cells/mm3 (IQR) | 491 (339, 677) |
Antenatal ART use, n (%) | |
<12 weeks | 24 (17) |
12–38 weeks | 88 (62) |
≥38 weeks | 29 (21) |
Calendar year of delivery, n (%) | |
1996–2001 | 47 (33) |
2002–2008 | 61 (43) |
2009–2014 | 33 (23) |
Gravidity, n (%) | |
1 | 13 (10) |
≥2 | 111 (90) |
Prior live births, n (%) | |
0 | 29 (22) |
1 | 45 (35) |
≥2 | 55 (43) |
Abbreviations. IQR, interquartile range; ART, antiretroviral therapy.
All characteristics measured at delivery. Missing data for HIV RNA (n=19), CD4 cell count (n=19), gravidity (n=17), and prior live births (n=12).